GLOMERULAR DISEASE
Clinical trials for GLOMERULAR DISEASE explained in plain language.
Never miss a new study
Get alerted when new GLOMERULAR DISEASE trials appear
Sign up with your email to follow new studies for GLOMERULAR DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug zigakibart tested for Long-Term kidney protection
Disease control Recruiting nowThis study looks at the long-term safety of a drug called zigakibart for people with IgA nephropathy, a kidney disease. It is for adults who have already finished another zigakibart study. Researchers will monitor side effects and check kidney function over 96 weeks.
Matched conditions: GLOMERULAR DISEASE
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 07:28 UTC
-
New combo therapy aims to calm immune attack on kidneys
Disease control Recruiting nowThis study tests whether combining two immune-suppressing drugs, rituximab and cyclosporine, can safely reduce protein leakage in the urine of people with membranous nephropathy, a kidney disease where the immune system damages kidney filters. About 30 adults with persistent prot…
Matched conditions: GLOMERULAR DISEASE
Phase: PHASE2 • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
Swelling stories: new survey aims to improve kidney drug tests
Knowledge-focused Recruiting nowThis study interviews 150 children, adults, and parents about their experiences with swelling caused by Nephrotic Syndrome. Researchers will use the information to create a survey that helps test new medications. No treatment is given; the goal is to better understand symptoms.
Matched conditions: GLOMERULAR DISEASE
Sponsor: University of Michigan • Aim: Knowledge-focused
Last updated May 11, 2026 20:46 UTC